Not all clients with CLL need therapy. Irrespective of all current developments, the iwCLL nevertheless recommends watchful observation for clients with asymptomatic disease.86 This suggestion relies on a minimum of two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).A